Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation

The present review aims to elucidate the emerging role played by cannabinomimetic compounds in the control of mast cell activation. Mast cells are immune competent cells strategically localised at the…

Continue ReadingCannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study

Fifteen cats with eosinophilic granuloma or eosinophilic plaque were given PLR 120 at the dosage of 10 mg kg−1 twice daily for one month. PLR‐120 down‐modulates mast cell degranulation via a…

Continue ReadingClinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study

Cannabinoid system in the skin – a possible target for future therapies in dermatology

Abstract: Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is…

Continue ReadingCannabinoid system in the skin – a possible target for future therapies in dermatology

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals

Endocannabinoids have analgesic/anti-inflammatory properties. The biology of endocannabinoids, their receptors, signalling mechanisms and role in the regulation of physiological processes have been extensively reviewed. This review focuses on the role…

Continue ReadingPalmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals

‘Trojan horse’ drug that tricks cancer cells into letting it inside ‘completely eliminates’ bone, pancreatic and colon forms of the disease in a trial

Approach binds chemo to fat, which tumours use as fuel to growThe fat gets taken up by malignant cells with the cancer-killing therapy in towOnce inside a tumour, the drug…

Continue Reading‘Trojan horse’ drug that tricks cancer cells into letting it inside ‘completely eliminates’ bone, pancreatic and colon forms of the disease in a trial

Does CBD Calm Essential Tremor? Researchers Are Looking Into It

The University of California San Diego’s Center for Medicinal Cannabis Research announced Tuesday that the Drug Enforcement Administration has OK’d its plans to import capsules containing two key cannabis compounds — CBD…

Continue ReadingDoes CBD Calm Essential Tremor? Researchers Are Looking Into It

Marijuana & Essential Tremor: A Natural Treatment

Most people become suspicious when they hear the words ‘alternative medicine’ – however this shouldn’t always be the case. There is recent evidence to suggest that some of these unique medicinal…

Continue ReadingMarijuana & Essential Tremor: A Natural Treatment

Open label evaluation of cannabidiol in dystonic movement disorders

Cannabidiol (CBD) a nonpsychoactive cannabinoid of Cannabis, was given to 5 patients with dystonic movement disorders in a preliminary open pilotstudy. Oral doses of CBD rising from 100 t 600…

Continue ReadingOpen label evaluation of cannabidiol in dystonic movement disorders

Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor

Cognitive and motor disturbances are serious consequences of tremor induced by motor disorders. Despite a lack of effective clinical treatment, some potential therapeutic agents have been used to alleviate the…

Continue ReadingCannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor

Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Tremor arises from an involuntary, rhythmic muscle contraction/relaxation cycle and is a common disabling symptom of many motor-related diseases such as Parkinson disease, multiple sclerosis, Huntington disease, and forms of…

Continue ReadingCannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics

Cannabis has been used for many medicinal purposes, including management of spasms, dystonia, and dyskinesias, with variable success. Its use for tetanus was described in the second century BCE, but…

Continue ReadingCannabis in the Treatment of Dystonia, Dyskinesias, and Tics

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

The cannabinoid receptors for Δ9-THC, and particularly, the CB1 receptor, as well as its endogenous ligands, the endocannabinoids anandamide and 2-arachidonoylglycerol, are deeply involved in all aspects of the control of…

Continue ReadingCannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats

The antinociceptive action of cannabinoids in acute and inflammatory pain states have been well-documented. There is also accumulating evidence suggesting that cannabinoids are effective analgesics in chronic pain conditions. WIN 55,212-2, a mixed CB1 and CB2…

Continue ReadingThe effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy

OBJECTIVE Cannabinoid receptor 1 (CB1) is localized in the central nervous system and in peripheral tissues involved in energy metabolism control. However, CB1 receptors are also expressed at low level within…

Continue ReadingCannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy

Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy

Endocannabinoids and cannabinoid 1 (CB1) receptors have been implicated in cardiac dysfunction, inflammation, and cell death associated with various forms of shock, heart failure, and atherosclerosis, in addition to their…

Continue ReadingCannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy

Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors

Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results in painful conditions. Then, we aimed to…

Continue ReadingCannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors

Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.

BACKGROUND: Destruction of the insulin-producing beta cells in type 1 diabetes (T1D) is induced by invasion of immune cells causing pancreatic inflammation. Cannabidiol (CBD), a phytocannabinoid, derived from the plant,…

Continue ReadingExperimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.

Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol

Aldose reductase (ALR2) is a key enzyme involved in diabetic complications and the search for new aldose reductase inhibitors (ARIs) is currently very important. The synthetic ARIs are often associated with deleterious side effects and medicinal…

Continue ReadingInhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.

OBJECTIVE: Cannabidiol (CBD) and Δ(9)-tetrahydrocannabivarin (THCV) are nonpsychoactive phytocannabinoids affecting lipid and glucose metabolism in animal models. This study set out to examine the effects of these compounds in patients…

Continue ReadingEfficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.